US 9132200
Oligomer-calcium channel blocker conjugates
granted A61KA61K31/4418A61K31/4422
Quick answer
US patent 9132200 (Oligomer-calcium channel blocker conjugates) held by Nektar Therapeutics expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/4418, A61K31/4422, A61K47/60, A61P